Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet ...

SUNNYVALE, Calif., Oct. 27, 2016 /PRNewswire/ -- With the flu season fast approaching, healthcare providers no longer need to choose between a fast test result or an accurate test result for ...

Learn more about whether iRhythm Technologies, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

US official says Trump confident China will not invade Taiwan during his term The isothermal nucleic acid amplification technology market has evolved significantly due to the growing need for ...

Consumption, phthisis, the white plague—a killer by any other name, tuberculosis (TB) has stalked humanity since at least the ...

Ongoing education and training are essential to empower healthcare professionals to fully utilize AI's capabilities while ...

BMRT's breakthrough reinforces its mission to leverage quantum physics to benefit mankind. This innovation aligns with the ...

Through their development of iPSCs, Pluristyx recognized the critical importance of cellular biopreservation across the cell therapy workflow. In the process, the company identified a novel ...

The global market for COVID-19 saliva sampling tests is projected to experience steady growth in the coming years, with estimated sales reaching USD 3,671.4 million in 2024 and expanding to USD 5,382.

Arizona State Retirement System grew its holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) by 12.4% during the ...